Assembly Biosciences (ASMB) Non-Current Assets (2010 - 2026)

Assembly Biosciences' Non-Current Assets history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 17.05% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $12.4 million (up 7.23% YoY), while the FY2025 annual figure was $3.0 million, down 17.03% from the prior year.
• Non-Current Assets was $2.9 million for Q1 2026 at Assembly Biosciences, down from $3.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $32.0 million in Q1 2022 to a low of $2.0 million in Q3 2023.
• Historically, Non-Current Assets has averaged $5.9 million across 5 years, with a median of $3.2 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets tumbled 89.45% in 2023, then surged 55.44% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $4.8 million in 2022, then plunged by 37.1% to $3.0 million in 2023, then increased by 20.72% to $3.7 million in 2024, then retreated by 17.03% to $3.0 million in 2025, then fell by 4.8% to $2.9 million in 2026.
• The last three Non-Current Assets figures came in at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.